June 24th 2021
The chief executive officer of Gamida Cell discussed upcoming research on 2 of their investigational agents, GDA-201 and omidubicel, for hematological malignancies.
June 22nd 2021
The chief executive officer of Gamida Cell discussed the company's novel approach to cell proliferation.